Chronic Postsurgical Pain Following Lung Transplantation: Characteristics, Risk Factors, Treatment, and Prevention: A Narrative Review.

IF 4.1 2区医学 Q1 CLINICAL NEUROLOGY Pain and Therapy Pub Date : 2024-08-01 Epub Date: 2024-05-29 DOI:10.1007/s40122-024-00615-4

Xinchen Tao, Ge Luo, Jie Xiao, Yuanyuan Yao, Qi Gao, Jingcheng Zou, Tingting Wang, Zhenzhen Cheng, Dawei Sun, Min Yan

引用次数: 0

Abstract

Chronic pain after lung transplantation (LTx) can substantially reduce quality of life (QoL), yet current consensus guidelines say little about how to prevent or manage it. Research on pain after LTx has tended to focus on acute rather than chronic pain, and it has not extensively examined the factors associated with onset or resolution of chronic pain, which differ from factors influencing chronic pain after general thoracic surgery. This narrative review explores what is known about the epidemiology and risk factors of chronic pain after LTx, as well as effective ways to treat or prevent it. The review identifies key questions and issues that should be the focus of future research.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

肺移植术后慢性疼痛：特征、风险因素、治疗和预防：叙述性综述。

肺移植术（LTx）后的慢性疼痛会大大降低患者的生活质量（QoL），但目前的共识指南对如何预防或控制慢性疼痛却知之甚少。有关肺移植术后疼痛的研究往往侧重于急性疼痛而非慢性疼痛，而且尚未广泛研究与慢性疼痛的发生或缓解相关的因素，这些因素与影响普通胸外科手术后慢性疼痛的因素不同。本叙述性综述探讨了有关 LTx 术后慢性疼痛的流行病学和风险因素，以及治疗或预防慢性疼痛的有效方法。综述指出了未来研究应关注的关键问题。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Pain and Therapy CLINICAL NEUROLOGY-

CiteScore

6.60

自引率

5.00%

发文量

110

审稿时长

6 weeks

期刊介绍： Pain and Therapy is an international, open access, peer-reviewed, rapid publication journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of pain therapies and pain-related devices. Studies relating to diagnosis, pharmacoeconomics, public health, quality of life, and patient care, management, and education are also encouraged. Areas of focus include, but are not limited to, acute pain, cancer pain, chronic pain, headache and migraine, neuropathic pain, opioids, palliative care and pain ethics, peri- and post-operative pain as well as rheumatic pain and fibromyalgia. The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research, reviews, case reports, trial protocols, short communications such as commentaries and editorials, and letters. The journal is read by a global audience and receives submissions from around the world. Pain and Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of all scientifically and ethically sound research.